Citius Pharmaceuticals, Inc. Operating Cash Flow
Citius Pharmaceuticals, Inc. (CTXR) reported Operating Cash Flow of -$22.99 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$8.68M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.30M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$13.01M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$11.88M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$26.55M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$28.20M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$29.06M.
- Citius Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$28.36M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 13 month | Net Cash Provided by (Used in) Operating Activities 16 month | Net Cash Provided by (Used in) Operating Activities 19 month | Net Cash Provided by (Used in) Operating Activities 22 month | Net Cash Provided by (Used in) Operating Activities 25 month | Net Cash Provided by (Used in) Operating Activities 28 month | Net Cash Provided by (Used in) Operating Activities 31 month | Net Cash Provided by (Used in) Operating Activities 34 month | Net Cash Provided by (Used in) Operating Activities 37 month | Net Cash Provided by (Used in) Operating Activities 40 month | Net Cash Provided by (Used in) Operating Activities 43 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$9.98M derived: sum of 2 quarters · filed 2026-08-14 | -$22.99M 10-Q · filed 2026-08-14 | -$34.87M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2026-03-31 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$14.31M 10-Q · filed 2026-05-15 | -$26.19M derived: sum of 3 quarters · filed 2026-05-15 | -$31.60M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2025-12-31 | -$13.01M 10-Q · filed 2026-02-13 | -$24.89M derived: sum of 2 quarters · filed 2026-02-13 | -$30.30M derived: sum of 3 quarters · filed 2026-08-14 | -$34.84M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2025-09-30 | -$11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | -$17.29M derived: sum of 2 quarters · filed 2026-08-14 | -$21.83M derived: sum of 3 quarters · filed 2026-08-14 | -$26.55M 10-K · filed 2025-12-23 | ||||||||||||||||
| 2025-06-30 | -$5.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$9.95M derived: sum of 2 quarters · filed 2026-08-14 | -$14.67M 10-Q · filed 2026-08-14 | -$20.58M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||||
| 2025-03-31 | -$4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$9.27M 10-Q · filed 2026-05-15 | -$15.18M derived: sum of 3 quarters · filed 2026-05-15 | -$23.55M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||||
| 2024-12-31 | -$4.73M 10-Q · filed 2026-02-13 | -$10.64M derived: sum of 2 quarters · filed 2026-02-13 | -$19.01M derived: sum of 3 quarters · filed 2026-02-13 | -$26.79M derived: sum of 4 quarters · filed 2026-02-13 | ||||||||||||||||
| 2024-09-30 | -$5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | -$14.28M derived: sum of 2 quarters · filed 2025-12-23 | -$22.07M derived: sum of 3 quarters · filed 2025-12-23 | -$28.20M 10-K · filed 2025-12-23 | ||||||||||||||||
| 2024-06-30 | -$8.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$16.15M derived: sum of 2 quarters · filed 2025-08-12 | -$22.29M 10-Q · filed 2025-08-12 | -$29.09M derived: sum of 4 quarters · filed 2025-08-12 | ||||||||||||||||
| 2024-03-31 | -$7.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$13.92M 10-Q · filed 2025-05-14 | -$20.72M derived: sum of 3 quarters · filed 2025-05-14 | -$30.30M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||||||||
| 2023-12-31 | -$6.14M 10-Q · filed 2025-02-14 | -$12.94M derived: sum of 2 quarters · filed 2025-02-14 | -$22.52M derived: sum of 3 quarters · filed 2025-02-14 | -$30.37M derived: sum of 4 quarters · filed 2025-02-14 | ||||||||||||||||
| 2023-09-30 | -$6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | -$16.38M derived: sum of 2 quarters · filed 2024-12-27 | -$24.24M derived: sum of 3 quarters · filed 2024-12-27 | -$29.06M 10-K · filed 2024-12-27 | ||||||||||||||||
| 2023-06-30 | -$9.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-12 | -$17.44M derived: sum of 2 quarters · filed 2024-08-12 | -$22.26M 10-Q · filed 2024-08-12 | -$28.59M derived: sum of 4 quarters · filed 2024-08-12 | ||||||||||||||||
| 2023-03-31 | -$7.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | -$12.68M 10-Q · filed 2024-05-14 | -$19.01M derived: sum of 3 quarters · filed 2024-05-14 | -$26.72M derived: sum of 4 quarters · filed 2024-05-14 | ||||||||||||||||
| 2022-12-31 | -$4.82M 10-Q · filed 2024-02-14 | -$11.16M derived: sum of 2 quarters · filed 2024-02-14 | -$18.87M derived: sum of 3 quarters · filed 2024-02-14 | -$28.53M derived: sum of 4 quarters · filed 2024-02-14 | ||||||||||||||||
| 2022-09-30 | -$6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | -$14.04M derived: sum of 2 quarters · filed 2023-12-29 | -$23.71M derived: sum of 3 quarters · filed 2023-12-29 | -$28.36M 10-K · filed 2023-12-29 | ||||||||||||||||
| 2022-06-30 | -$7.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$17.38M derived: sum of 2 quarters · filed 2023-08-14 | -$22.03M 10-Q · filed 2023-08-14 | -$27.62M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||||||
| 2022-03-31 | -$9.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$14.32M 10-Q · filed 2023-05-12 | -$19.91M derived: sum of 3 quarters · filed 2023-05-12 | -$24.73M derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||||||||
| 2021-12-31 | -$4.65M 10-Q · filed 2023-02-10 | -$10.24M derived: sum of 2 quarters · filed 2023-02-10 | -$15.07M derived: sum of 3 quarters · filed 2023-02-10 | -$19.34M derived: sum of 4 quarters · filed 2023-02-10 | ||||||||||||||||
| 2021-09-30 | -$5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | -$10.41M derived: sum of 2 quarters · filed 2022-12-22 | -$14.69M derived: sum of 3 quarters · filed 2022-12-22 | -$24.25M 10-K · filed 2022-12-22 | ||||||||||||||||
| 2021-06-30 | -$4.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$9.09M derived: sum of 2 quarters · filed 2022-08-11 | -$18.66M 10-Q · filed 2022-08-11 | -$22.02M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||||||
| 2021-03-31 | -$4.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$13.84M 10-Q · filed 2022-05-12 | -$17.19M derived: sum of 3 quarters · filed 2022-05-12 | -$21.18M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||||
| 2020-12-31 | -$9.56M 10-Q · filed 2022-02-10 | -$12.92M derived: sum of 2 quarters · filed 2022-02-10 | -$16.91M derived: sum of 3 quarters · filed 2022-02-10 | -$21.38M derived: sum of 4 quarters · filed 2022-02-10 | ||||||||||||||||
| 2020-09-30 | -$3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | -$7.35M derived: sum of 2 quarters · filed 2021-12-15 | -$11.82M derived: sum of 3 quarters · filed 2021-12-15 | -$16.93M 10-K · filed 2021-12-15 | ||||||||||||||||
| 2020-06-30 | -$3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | -$8.46M derived: sum of 2 quarters · filed 2021-08-12 | -$13.57M 10-Q · filed 2021-08-12 | -$16.48M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||||||
| 2020-03-31 | -$4.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | -$9.58M 10-Q · filed 2021-05-13 | -$12.49M derived: sum of 3 quarters · filed 2021-05-13 | -$16.01M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||||
| 2019-12-31 | -$5.11M 10-Q · filed 2021-02-11 | -$8.02M derived: sum of 2 quarters · filed 2021-02-11 | -$11.54M derived: sum of 3 quarters · filed 2021-02-11 | -$15.39M derived: sum of 4 quarters · filed 2021-02-11 | ||||||||||||||||
| 2019-09-30 | -$2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | -$6.43M derived: sum of 2 quarters · filed 2020-12-16 | -$10.28M derived: sum of 3 quarters · filed 2020-12-16 | -$12.44M 10-K · filed 2020-12-16 | ||||||||||||||||
| 2019-06-30 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | -$7.37M derived: sum of 2 quarters · filed 2020-08-14 | -$9.53M 10-Q · filed 2020-08-14 | -$12.04M derived: sum of 4 quarters · filed 2020-08-14 | ||||||||||||||||
| 2019-03-31 | -$3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | -$6.01M 10-Q · filed 2020-05-14 | -$8.51M derived: sum of 3 quarters · filed 2020-05-14 | -$10.76M derived: sum of 4 quarters · filed 2020-05-14 | ||||||||||||||||
| 2018-12-31 | -$2.16M 10-Q · filed 2020-02-13 | -$4.66M derived: sum of 2 quarters · filed 2020-02-13 | -$6.91M derived: sum of 3 quarters · filed 2020-02-13 | -$11.04M derived: sum of 4 quarters · filed 2020-02-13 | ||||||||||||||||
| 2018-09-30 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -$4.75M derived: sum of 2 quarters · filed 2019-12-16 | -$8.88M derived: sum of 3 quarters · filed 2019-12-16 | -$11.32M 10-K · filed 2019-12-16 | ||||||||||||||||
| 2018-06-30 | -$2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$6.37M derived: sum of 2 quarters · filed 2019-08-14 | -$8.81M 10-Q · filed 2019-08-14 | -$12.24M derived: sum of 4 quarters · filed 2019-12-16 | ||||||||||||||||
| 2018-03-31 | -$4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$6.57M 10-Q · filed 2019-05-15 | -$10.00M derived: sum of 3 quarters · filed 2019-12-16 | -$12.40M derived: sum of 4 quarters · filed 2019-12-16 | ||||||||||||||||
| 2017-12-31 | -$2.44M 10-Q · filed 2019-02-14 | -$5.87M derived: sum of 2 quarters · filed 2019-12-16 | -$8.27M derived: sum of 3 quarters · filed 2019-12-16 | -$9.10M derived: sum of 4 quarters · filed 2019-12-16 | ||||||||||||||||
| 2017-09-30 | -$3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -$5.83M derived: sum of 2 quarters · filed 2019-12-16 | -$6.66M derived: sum of 3 quarters · filed 2019-12-16 | -$7.97M 10-K · filed 2019-12-16 | ||||||||||||||||
| 2017-06-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$3.23M derived: sum of 2 quarters · filed 2018-08-14 | -$4.54M 10-Q · filed 2018-08-14 | -$6.31M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||||||
| 2017-03-31 | -$824.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | -$2.14M 10-Q · filed 2018-05-11 | -$3.91M derived: sum of 3 quarters · filed 2018-12-11 | -$6.47M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||||||
| 2016-12-31 | -$1.31M 10-Q · filed 2018-02-14 | -$3.08M derived: sum of 2 quarters · filed 2018-12-11 | -$5.64M derived: sum of 3 quarters · filed 2018-12-11 | -$6.52M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||||||
| 2016-09-30 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | -$4.33M derived: sum of 2 quarters · filed 2018-12-11 | -$5.20M derived: sum of 3 quarters · filed 2018-12-11 | -$5.90M 10-K · filed 2018-12-11 | ||||||||||||||||
| 2016-06-30 | -$2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$3.44M derived: sum of 2 quarters · filed 2017-08-14 | -$4.13M 10-Q · filed 2017-08-14 | -$4.84M derived: sum of 4 quarters · filed 2017-12-13 | ||||||||||||||||
| 2016-03-31 | -$874.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | -$1.57M 10-Q · filed 2017-05-15 | -$2.28M derived: sum of 3 quarters · filed 2017-12-13 | -$2.91M derived: sum of 4 quarters · filed 2017-12-13 | ||||||||||||||||
| 2015-12-31 | -$697.09K 10-Q · filed 2017-02-14 | -$1.40M derived: sum of 2 quarters · filed 2017-12-13 | -$2.03M derived: sum of 3 quarters · filed 2017-12-13 | -$2.35M derived: sum of 4 quarters · filed 2017-12-13 | ||||||||||||||||
| 2015-09-30 | -$705.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-13 | -$1.33M derived: sum of 2 quarters · filed 2017-12-13 | -$1.65M derived: sum of 3 quarters · filed 2017-12-13 | -$2.39M 10-K · filed 2017-12-13 | ||||||||||||||||
| 2015-06-30 | -$628.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | -$945.29K derived: sum of 2 quarters · filed 2016-08-15 | -$1.68M 10-Q · filed 2016-08-15 | -$1.26M derived: sum of 4 quarters · filed 2016-12-23 | ||||||||||||||||
| 2015-03-31 | -$316.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | -$1.05M 10-Q · filed 2016-05-20 | -$632.04K derived: sum of 3 quarters · filed 2016-12-23 | -$680.52K derived: sum of 4 quarters · filed 2016-12-23 | ||||||||||||||||
| 2014-12-31 | -$734.82K 10-Q · filed 2016-02-12 | -$315.16K derived: sum of 2 quarters · filed 2016-12-23 | -$363.64K derived: sum of 3 quarters · filed 2016-12-23 | -$396.11K derived: sum of 4 quarters · filed 2016-12-23 | ||||||||||||||||
| 2014-09-30 | $419.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $371.18K derived: sum of 2 quarters · filed 2016-12-23 | -$183.16K 10-K · filed 2015-12-14 | -$183.16K 10-K · filed 2016-12-23 | ||||||||||||||||
| 2014-06-30 | -$48.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-13 | -$80.95K derived: sum of 2 quarters · filed 2015-08-13 | -$602.83K 10-Q · filed 2015-08-13 | -$26.00K 10-Q · filed 2014-08-14 | -$610.23K derived: sum of 4 quarters · filed 2015-08-13 | |||||||||||||||
| 2014-03-31 | -$32.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-13 | -$554.34K 10-Q · filed 2015-05-13 | -$21.01K 10-Q · filed 2014-05-15 | -$561.74K derived: sum of 3 quarters · filed 2015-05-13 | -$564.98K derived: sum of 4 quarters · filed 2015-05-13 | -$98.22K 10-Q · filed 2014-05-15 | ||||||||||||||
| 2013-12-31 | -$521.88K 10-Q · filed 2015-02-17 | -$17.52K 10-Q · filed 2014-02-19 | -$529.28K derived: sum of 2 quarters · filed 2015-02-17 | -$532.51K derived: sum of 3 quarters · filed 2015-02-17 | -$1.10M 10-K · filed 2015-12-14 | -$94.73K 10-Q · filed 2014-02-19 | ||||||||||||||
| 2013-09-30 | -$7.40K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$10.63K derived: sum of 2 quarters · filed 2014-08-14 | -$20.37K derived: sum of 3 quarters · filed 2014-08-14 | -$20.60K 10-K · filed 2014-02-06 | -$77.21K 10-K · filed 2014-02-06 | |||||||||||||||
| 2013-06-30 | -$3.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | -$12.97K derived: sum of 2 quarters · filed 2014-08-14 | -$13.21K 10-Q · filed 2014-08-14 | -$18.66K derived: sum of 4 quarters · filed 2014-08-14 | -$69.81K 10-Q · filed 2013-09-18 | |||||||||||||||
| 2013-03-31 | -$9.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | -$9.97K 10-Q · filed 2014-05-15 | -$15.42K derived: sum of 3 quarters · filed 2014-05-15 | -$21.40K derived: sum of 4 quarters · filed 2014-05-15 | -$66.58K 10-Q · filed 2013-05-13 | |||||||||||||||
| 2012-12-31 | -$236.00 10-Q · filed 2014-02-19 | -$5.68K derived: sum of 2 quarters · filed 2014-02-19 | -$11.66K derived: sum of 3 quarters · filed 2014-02-19 | -$917.80K 10-KT · filed 2014-12-29 | -$56.84K 10-Q · filed 2013-02-08 | |||||||||||||||
| 2012-09-30 | -$5.45K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$11.43K derived: sum of 2 quarters · filed 2014-02-06 | -$18.13K derived: sum of 3 quarters · filed 2014-02-06 | -$20.32K 10-K · filed 2014-02-06 | -$56.60K 10-K · filed 2013-01-15 | |||||||||||||||
| 2012-06-30 | -$5.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-18 | -$12.68K derived: sum of 2 quarters · filed 2013-09-18 | -$14.88K 10-Q · filed 2013-09-18 | -$19.82K derived: sum of 4 quarters · filed 2013-09-18 | -$51.16K 10-Q · filed 2012-08-17 | |||||||||||||||
| 2012-03-31 | -$6.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-13 | -$8.89K 10-Q · filed 2013-05-13 | -$13.84K derived: sum of 3 quarters · filed 2013-05-13 | -$18.98K derived: sum of 4 quarters · filed 2013-05-13 | -$45.18K 10-Q · filed 2012-05-11 | |||||||||||||||
| 2011-12-31 | -$2.20K 10-Q · filed 2013-02-08 | -$7.14K derived: sum of 2 quarters · filed 2013-02-08 | -$12.28K derived: sum of 3 quarters · filed 2013-02-08 | -$19.94K derived: sum of 4 quarters · filed 2013-02-08 | -$38.48K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2011-09-30 | -$4.94K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-15 | -$10.09K derived: sum of 2 quarters · filed 2013-01-15 | -$17.74K derived: sum of 3 quarters · filed 2013-01-15 | -$20.78K 10-K · filed 2013-01-15 | -$36.28K 10-K · filed 2012-01-13 | |||||||||||||||
| 2011-06-30 | -$5.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | -$12.80K derived: sum of 2 quarters · filed 2012-08-17 | -$15.84K 10-Q · filed 2012-08-17 | -$31.34K 10-Q · filed 2011-08-26 | ||||||||||||||||
| 2011-03-31 | -$7.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-11 | -$10.70K 10-Q · filed 2012-05-11 | ||||||||||||||||||
| 2010-12-31 | -$3.04K 10-Q · filed 2012-02-14 | |||||||||||||||||||
| 2010-09-30 | -$15.50K 10-K · filed 2012-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |